Introduction {#section6-1179069519833966}
============

Posttraumatic stress disorder (PTSD) is associated with significant symptoms that severely impact one's quality of life.^[@bibr1-1179069519833966]^ These posttraumatic symptoms (PTS) include perseverative thinking (rumination of traumatic events), which is linked with the development and maintenance of other symptoms.^[@bibr2-1179069519833966]^ Furthermore, contributing to the chronicity of symptoms, PTS is associated with compromised cognitive functioning^[@bibr3-1179069519833966]^ and emotional processes.^[@bibr4-1179069519833966],[@bibr5-1179069519833966]^ Similar to individuals with PTS, a small but significant percentage of individuals with a history of mild traumatic brain injury (mTBI) report chronic symptoms that impact their quality of life,^[@bibr6-1179069519833966]^ show cognitive decrements, and have compromised ability to regulate emotions.^[@bibr5-1179069519833966],[@bibr7-1179069519833966]^ To complicate matters, there is a high comorbidity of PTS in military personnel who sustain an mTBI while deployed^[@bibr8-1179069519833966]^ due to the trauma experienced when sustaining a head injury (eg, casualties occurring from an improvised explosive device \[IED\]). Evidence indicates that individuals with PTS and comorbid mTBI have worse clinical outcomes compared with PTS alone based on symptom severity^[@bibr5-1179069519833966]^ and treatment response.^[@bibr9-1179069519833966]^ Characterizing the neural functional correlates of both PTS and mTBI using magnetic resonance imaging (MRI) has shown to have some utility.^[@bibr10-1179069519833966],[@bibr11-1179069519833966]^ By characterizing different default mode network (DMN), neural signatures may improve the process of teasing apart the etiology of cases with potential co-morbidities with overlapping symptomatology. Furthermore, this approach might provide insight of potential mechanistic properties underlying pathophysiologic-related functional impairments.

Task-based functional neuroimaging reveals disruptions in the neural circuitry associated with PTS, specifically the hippocampus, amygdala, insula, superior and middle temporal gyrus, cingulate gyrus, and medial frontal gyrus.^[@bibr5-1179069519833966],[@bibr7-1179069519833966]^ Individuals with chronic mTBI show increased activation of regions implicated in cognitive-affective process^[@bibr7-1179069519833966]^ such as the insula and temporal lobe. Recent studies reveal compromised neural connectivity in PTS and mTBI, implicating the middle frontal gyrus (MFG) or the dorsolateral prefrontal cortex (dlPFC), insula, amygdala, and hippocampus, with the MFG being the pivotal source of network disruption.^[@bibr10-1179069519833966],[@bibr11-1179069519833966]^ Overall, both PTS and mTBI with co-occurring PTS may have disrupted neural circuitry with top-down origins necessary for regulation of affective processes that modulate symptom expression.

The DMN consists of interacting brain regions (eg, the medial prefrontal cortex, posterior cingulate cortex (PCC), precuneus, inferior parietal lobules, and temporal lobe regions) that are active when an individual is not focusing on an exogenous stimulus.^[@bibr12-1179069519833966]^ Power et al^[@bibr13-1179069519833966]^ identified 58 functionally homogeneous brain regions of the DMN. The DMN reflects internally focused thought that occurs when individuals are left undisturbed.^[@bibr14-1179069519833966]^ While undisturbed, individuals are prone to mind-wandering, which results in thinking about one's self, remembering events, or envisaging the future.^[@bibr14-1179069519833966]^

Resting state connectivity of the DMN is disrupted in individuals with PTS.^[@bibr15-1179069519833966]^ Evidence shows disrupted connectivity between the PCC and hippocampus,^[@bibr16-1179069519833966]^ the anterior cingulate cortex (ACC) and parahippocampus,^[@bibr15-1179069519833966],[@bibr17-1179069519833966]^ precuneus,^[@bibr17-1179069519833966]^ and ventromedial prefrontal cortex (vmPFC).^[@bibr18-1179069519833966]^ This disruption is posited to underpin ruminating thought processes. In active-duty military populations with a high prevalence of mTBI and subsequent comorbid PTS, exploring potential neural connectivity signatures may be beneficial for differentiating the mechanisms underpinning these combat-related neuropsychiatric conditions as well as improving individualized, targeted treatments.

A prominent limitation in the literature is that studies most often report only "static" functional connectivity (SFC) between regions and fail to assess temporal variation of the connectivity, or in other terms, dynamic FC (DFC). Static functional connectivity only measures a time-compressed snapshot of connectivity as it represents average connectivity over the entire duration of the scan, ignoring the changes in connectivity that occur naturally over the course of several minutes of the scan. Lower temporal variability (ie, vDFC) is associated with both neurologic and psychiatric conditions,^[@bibr10-1179069519833966],[@bibr16-1179069519833966],[@bibr19-1179069519833966][@bibr20-1179069519833966][@bibr21-1179069519833966]--[@bibr22-1179069519833966]^ including PTSD and with and without mTBI,^[@bibr11-1179069519833966]^ suggesting a lack of cognitive flexibility (CF) associated with these neuropsychiatric conditions. Together, strength (SFC) and temporal variability (vDFC) of connectivity better explain the relationship between neural regions and ultimately better characterize these combat-related neuropsychiatric conditions.

In this study, we assessed both SFC and vDFC as objective measures of disrupted or dysregulated neurocircuitry and measures of cognitive functioning and psychological health, in active-duty Army soldiers who were categorized into one of the 3 groups: healthy controls versus a group screened positive for elevated PTS versus a group with mTBI and comorbid PTS (mTBI + PTS). Given that intrusive thoughts, dissociation, and avoidance behaviors are hallmark symptoms of PTSD, it is likely dysregulation of the DMN neurocircuitry will be observed in both the PTS and mTBI + PTS groups compared with the control group. Therefore, we hypothesized that the mTBI + PTS group will have a greater number reduced strength (SFC) and variance (vDFC) of connectivities within the DMN than the PTS alone group. Furthermore, we predict that severity of deficits in central executive functioning (EF) and greater psychological health symptoms in both diagnostic groups are also likely to be associated with dysregulated neurocircuitry.

Materials and Methods {#section7-1179069519833966}
=====================

Recruitment {#section8-1179069519833966}
-----------

This study's protocol was reviewed and approved by the U.S. Army Medical Research and Materiel Command Institutional Review Board (MRMC IRB) and the Auburn University IRB. In all, 78 active-duty U.S. Army soldiers, with prior deployment(s) to Iraq or Afghanistan as part of Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF), were recruited from Fort Rucker, AL and Fort Benning, GA to participate in this study. In addition to word of mouth, recruitment flyers and posters were placed at behavioral health clinics and other instillation facilities frequented by soldiers. Interested soldiers contacted investigators via phone or email provided on the flyers/posters. Candidates were screened for MRI contraindication, PTSD, and traumatic brain injury history. Eligible volunteers provided written informed consent. A study physician reviewed soldiers' electronic medical records for exclusionary medical conditions (eg, MRI contraindications such as evidence of shrapnel). If cleared by the study physician, the soldier was contacted and scheduled for testing at the Auburn University MRI Research Center, Auburn, AL. Participants were re-consented and further screened on arrival at the testing site.

Participants {#section9-1179069519833966}
------------

Active-duty U.S. Army soldiers (aged between 18 and 50 years) were recruited from Fort Rucker, AL, USA and Fort Benning, GA, USA to voluntarily participate in the study. The study was conducted in accordance with the Declaration of Helsinki. The procedures were approved by Auburn University's Institutional Review Board (IRB) and the Headquarters U.S. Army Medical Research and Materiel Command, IRB (HQ USAMRMC IRB).

A total of 75 participants were enrolled in the study, all of which had prior deployment(s) in Afghanistan (OEF) and/or Iraq (OIF). Participants were 73% Caucasian, 12% African-American, and 8.5% Hispanic (non-white), with all other racial groups making up the remaining 6.5%. Subjects were grouped based on PTSD symptom severity using the PTSD Checklist-5^[@bibr23-1179069519833966]^ (PCL5) score, clinician referral, and medical history. Eligibility required the absence of any history of a moderate-to-severe TBI and no history of a *Diagnostic and Statistical Manual of Mental Disorders* (4th ed.; Text Revision; *DSM*-IV-TR) or *Diagnostic and Statistical Manual of Mental Disorders* (5th ed.; *DSM*-V) diagnosis of a psychotic disorder (eg, schizophrenia) or substance dependency disorder. After removing 11 women from the sample due to a significant group disparity in the ratio of women to men, and 4 additional participants due to acquisition error, our sample included data from 60 participants who fell into one of the 3 groups:

\(1\) A combat control group (n = 21) was made up of participants with a score \<20 on the PCL5 with no reported mTBI within the last 5 years. (2) A posttraumatic stress (PTS) group (n = 14) consisted of participants with no reported history of mTBI in the last 5 years and total score ⩾20 on the PCL5. (3) A comorbid mTBI + PTS group (n = 25) consisted of participants with a history of medically documented mTBI within the last 5 years and scores ⩾20 on the PCL5 and actively experiencing postconcussive symptoms as assessed via the Neurobehavioral Symptom Inventory (NSI).

In addition, we also tested effort to improve the validity of our assessment data. To this end, we administered the Test of Memory Malingering (TOMM),^[@bibr24-1179069519833966]^ which consists of 2 learning trials and a retention trial that uses pictures of common, everyday objects (eg, chair, pencil). A cut-off score (\<45 correct) was used to determine eligibility for participation in the study. All participants passed the TOMM on the first trial.

Measures {#section10-1179069519833966}
--------

### Clinical symptoms {#section11-1179069519833966}

Clinical symptoms were assessed using a battery of common measures including the PTSD Checklist-5,^[@bibr23-1179069519833966]^ NSI,^[@bibr25-1179069519833966]^ Zung Depression Scale (ZDS) and Zung Anxiety Scale (ZAS),^[@bibr26-1179069519833966],[@bibr27-1179069519833966]^ Epworth Sleepiness Scale^[@bibr28-1179069519833966]^ (ESS), Perceived Stress Scale^[@bibr29-1179069519833966]^ (PSS), AUDIT,^[@bibr30-1179069519833966]^ and Pittsburgh Sleep Quality Index^[@bibr31-1179069519833966]^ (PSQI).

### Neurocognitive function {#section12-1179069519833966}

For neurocognitive assessment, we administered the Central Nervous System-Vital Signs^®[@bibr32-1179069519833966]^ (CNS-VS). This study used 5 computerized CNS-VS subtests (verbal memory \[VM\], symbol digit coding, Stroop test, continuous performance test, and the shifting attention test). The domain scores calculated were VM, complex attention (CA), reaction time (RT), processing speed (PS), CF, and EF. All domain scores are presented as index scores, with a mean of 100 and standard deviation of 15.

More information about the clinical and neurocognitive measures is provided in the [supplemental document](https://journals.sagepub.com/doi/suppl/10.1177/1179069519833966) ([Appendix](https://journals.sagepub.com/doi/suppl/10.1177/1179069519833966)).

Procedures {#section13-1179069519833966}
----------

Participants arriving at the research lab for their scheduled testing appointment were re-screened for eligibility, thoroughly screened for MRI contraindications, and re-consented to ensure full comprehension of the study's procedures, benefits and their rights.

*Functional magnetic resonance imaging.* Participants were scanned in a 3T MAGNETOM Verio scanner (Siemens Healthcare, Erlangen, Germany) using T2\*-weighted multiband echo planar imaging (EPI) sequence in resting state (participants were required to keep their eyes open and not think of anything specific and fixated on a white cross displayed in dark background on the screen using an Avotec projection system), with TR = 600 ms, TE = 30 ms, voxel size = 3 × 3 × 5 mm^3^, FA = 55°, multiband factor = 2, 1000 volumes. Brain coverage was limited to cerebral cortex, subcortex, and midbrain (cerebellum was excluded).

Data analysis {#section14-1179069519833966}
-------------

### Non-imaging measures {#section15-1179069519833966}

Mean and standard deviation were calculated for clinical symptoms and neurocognitive measures. Ordinal data were analyzed using Kendall Tau B (τ*b*) test. Independent multivariate analyses of variance (MANOVAs), with pairwise comparisons and Bonferroni corrections to control for inflation in familywise error rate, were used for (1) demographic and descriptive variables---age, education, lifetime mTBIs, CES, LEC, CE, and AUDIT; (2) clinical symptoms---PCL-5, NSI, ESS, PSIQ, ZAS, ZDS, and PSS; and (3) neurocognitive scores---RT, CA, PS, CF, VM, and EF. Scatterplots showed there was reasonable normality.

### Functional magnetic resonance imaging data pre-processing {#section16-1179069519833966}

Standard resting-state functional magnetic resonance imaging (fMRI) pre-processing steps were carried out, including realignment, normalization to Montreal Neurological Institute (MNI) space, and detrending and regressing covariates (six head-motion parameters, white matter, and cerebrospinal fluid signal). Pre-processing was carried out using Data Processing Assistant for Resting-State fMRI^[@bibr33-1179069519833966]^ (DPARSF, v1.7), which is based on Statistical Parametric Mapping^[@bibr34-1179069519833966]^ (SPM8) and Resting-State fMRI Data Analysis Toolkit (REST).^[@bibr35-1179069519833966]^

The data were temporally normalized, rendering each timeseries with zero mean and unit variance. These data were then entered into a blind deconvolution algorithm^[@bibr36-1179069519833966]^ to reduce non-neural confound of the hemodynamic response function (HRF), thus estimating latent neuronal timeseries. This deconvolution is blind given that both HRF and the underlying latent neural timeseries are estimated from only the observed fMRI data. Specifically, we employed the method proposed by Wu et al,^[@bibr36-1179069519833966]^ which has gained wide usability and acceptance owing to its simplicity, interpretability, validity, and robustness.^[@bibr11-1179069519833966],[@bibr37-1179069519833966][@bibr38-1179069519833966]--[@bibr39-1179069519833966]^ Briefly, the method models resting-state fMRI data as event related with randomly occurring events using point processes, then estimates the best-fit voxel-specific HRFs, and then obtains latent neural time series using Weiner deconvolution.

Deconvolution was performed as confounds emerging from inter-subject and spatial variability of the HRF could give rise to a scenario wherein 2 fMRI timeseries have high directional connectivity while the underlying neural variables do not and vice versa.^[@bibr10-1179069519833966]^ Given the high dimensionality of whole-brain fMRI data, mean deconvolved fMRI timeseries were obtained from 58 functionally homogeneous brain regions of the DMN as defined in Power et al.^[@bibr13-1179069519833966]^

### fMRI post-processing analysis {#section17-1179069519833966}

Analysis of SFC and variance of dynamic functional connectivity (vDFC) was performed using custom MATLAB^®^ modules. Static functional connectivity was obtained as the Pearson correlation between pairs of time series, with it being obtained for all the time series pairs in the DMN. Dynamic functional connectivity was obtained using the sliding window method, with the window lengths determined based on time series stationarity using the augmented Dickey-Fuller (ADF) test, as described in Rangaprakash et al.^[@bibr21-1179069519833966]^ The vDFC was obtained by taking the variance of the DFC time series for each connection. A multivariate analysis of variance (MANOVA) followed by pairwise *t*-tests (*P* \< .05, false discovery rate (FDR) corrected) was used to compare differences in SFC and vDFC of the 58 region(s) of interest (ROI) timeseries between the control group versus PTSD group versus mTBI + PTS group ([Figure 1](#fig1-1179069519833966){ref-type="fig"}). Common neuroanatomy nomenclature was used in [Tables 4](#table4-1179069519833966){ref-type="table"} and [5](#table5-1179069519833966){ref-type="table"} to describe significant group differences in connectivity, which varies from that in [Figures 2](#fig2-1179069519833966){ref-type="fig"} and [3](#fig3-1179069519833966){ref-type="fig"}. This change was done to increase reader generalizability and utility of the study's findings.

![Regions of interest (ROIs) of the default mode network (DMN) as proposed in Power et al. These 58 ROIs were used in this study.](10.1177_1179069519833966-fig1){#fig1-1179069519833966}

![Connections exhibiting significantly different SFC for pairwise comparisons between groups: connections significantly different for (A) control \> PTS comparison and (B) control \> mTBI + PTS comparison. There were no significant connections for other pairwise comparisons (PTS \> control, mTBI + PTSD \> control, PTSD \> mTBI + PTS, or mTBI + PTS \> PTS). mTBI indicates mild traumatic brain injury; PTS, posttraumatic stress symptoms; PTSD, posttraumatic stress disorder; SFC, static functional connectivity.](10.1177_1179069519833966-fig2){#fig2-1179069519833966}

![Connections exhibiting significantly different vDFC for pairwise comparisons between groups: connections significantly different for (A) control \> PTS comparison, (B) control \> mTBI + PTS comparison, (C) PTS \> mTBI + PTS comparison, (D) PTS \> control, and (E) mTBI + PTS \> PTS. There were no significant connections for the mTBI + PTS \> control comparison. Connections that were higher in control group or less severe group (A-C) are shown in magenta with yellow nodes, while connections that were higher in disease group or more severe group (D and E) are shown in green with blue nodes. mTBI indicates mild traumatic brain injury; PTS, posttraumatic stress symptoms; PTSD, posttraumatic stress disorder; vDFC, variance of dynamic functional connectivity.](10.1177_1179069519833966-fig3){#fig3-1179069519833966}

### Connectivity associations {#section18-1179069519833966}

Associations were tested between 47 connectivity features (7 SFC and 40 vDFC connectivities identified in the MANOVA) and measures of neurocognitive functioning and clinical symptoms. Independent partial least squares (PLS) regression analyses^[@bibr21-1179069519833966]^ were performed to assess the aggregate association of significant connectivities found in this study with psychological health symptoms and neurocognitive functioning. We assessed this separately for combined features within each of these 2 groups of measures---(1) clinical symptom severity scores (PCL-5, NSI, AUDIT, PSS, PSQI, ESS, ZAS, and ZDS) and (2) neurocognitive functioning (CNS-VS subtest scores).

Results {#section19-1179069519833966}
=======

Demographics and descriptives {#section20-1179069519833966}
-----------------------------

The MANOVA for specific demographic variables and descriptives was significant, F~(7,14)~ = 6.2, *P* \< .001, $\eta_{p}^{2} = .47$ (Wilk Lambda), indicating there were significant group differences. Although the groups were matched in age and education, *P *\> .05 (and racial composition, τ*b* = .004, *P* = .970), there were significant group differences in scores on the Life Events Checklist, with both the PTS (*M* = 48.1; SD = 9.7) and mTBI + PTS (*M* = 42.8; SD = 9.6) groups having a greater number of lifetime experiences to traumatic events than the control group (*M* = 26.1; SD = 11.4), *P* \< .05. The difference between the PTS and mTBI + PTS was nonsignificant, *P* = .441. Although there were significant group differences in lifetime traumatic experiences, childhood familial experiences was not significantly different, *P \> *.05, between the groups as assessed using the Childhood Environment Scale.^[@bibr40-1179069519833966]^ In addition, there were significant group differences in scores on the Combat Exposure Scale^[@bibr41-1179069519833966]^ between all 3 groups in the order of mTBI + PTS (*M* = 28.8; SD = 9.0)* \> *PTS (*M* = 20.8; SD = 8.8)* \> *control (*M* = 8.0; SD = 10.4), *P* \< .05. There was a significant difference between the groups in the number of reported lifetime mTBIs, specifically between the mTBI + PTS group (*M* = 1.6; SD = 0.8) and both the control group (*M* = 0.4; SD = 0.7), *P* \< .001, and PTS group (*M* = 0.8; SD = 1.0), *P* = .031.

There were significant group differences in reported use of prescribed antidepressants, τ*b* = 2.8, *P* = .004, and benzodiazepines, τ*b* = 2.5, *P* = .013, medication, with the comorbid group having the highest frequency of use (antidepressant: Control = 5% vs PTS = 14% vs mTBI + PTS = 36%; benzodiazepines: Control = 0% vs PTS = 0% vs mTBI + PTS = 25%).

Clinical symptoms and neurocognitive function {#section21-1179069519833966}
---------------------------------------------

The results of the MANOVA for clinical symptom measures were significant, F~(7,14)~ = 6.7, *P* \< .001, $\eta_{p}^{2} = .49$ (Pillai Trace), indicating there were significant group differences on a number of different clinical scales ([Table 1](#table1-1179069519833966){ref-type="table"}). All *P* values remained significant after corrections for multiple comparisons, with the mTBI + PTS group having the highest scores out of the 3 groups on these respective measures.

###### 

Clinical symptoms and neurocognitive measures for the 3 groups.

![](10.1177_1179069519833966-table1)

  Clinical symptoms                  Control                                                              PTS                                                                  mTBI + PTS                                                    
  -------------------------- ------- ------------------------------------------------------------ ------- ------------------------------------------------------------ ------- ------------------------------------------------------------- --
  Posttraumatic symptoms     *M*     3.85                                                                 32.50                                                                52.52                                                         
  SD                         4.57                                                                 10.68                                                                15.48                                                                 
  *d*                                3.49[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           1.51[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           4.26^[a](#table-fn2-1179069519833966){ref-type="table-fn"}^   
  Post-concussive symptoms   *M*     7.15                                                                 25.00                                                                43.68                                                         
  SD                         4.93                                                                 16.17                                                                16.74                                                                 
  *d*                                1.49[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           1.14[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           2.96^[a](#table-fn2-1179069519833966){ref-type="table-fn"}^   
  Depression                 *M*     32.20                                                                40.83                                                                52.44                                                         
  SD                         7.30                                                                 11.90                                                                10.15                                                                 
  *d*                                0.87                                                                 1.45[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           2.29^[a](#table-fn2-1179069519833966){ref-type="table-fn"}^   
  Anxiety                    *M*     29.80                                                                38.50                                                                51.08                                                         
  SD                         5.56                                                                 12.77                                                                9.95                                                                  
  *d*                                0.88[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           1.10[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           2.64^[a](#table-fn2-1179069519833966){ref-type="table-fn"}^   
  Sleepiness                 *M*     8.25                                                                 8.00                                                                 13.32                                                         
  SD                         3.19                                                                 3.59                                                                 5.41                                                                  
  *d*                                0.01                                                                 1.16[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           1.14^[a](#table-fn2-1179069519833966){ref-type="table-fn"}^   
  Perceived stress           *M*     15.40                                                                25.08                                                                32.16                                                         
  SD                         6.95                                                                 8.61                                                                 9.06                                                                  
  *d*                                1.24[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           0.80                                                                 2.08^[a](#table-fn2-1179069519833966){ref-type="table-fn"}^   
  Sleep quality              *M*     23.65                                                                22.50                                                                46.60                                                         
  SD                         17.63                                                                15.15                                                                25.29                                                                 
  *d*                                0.07                                                                 1.16[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           1.05^[a](#table-fn2-1179069519833966){ref-type="table-fn"}^   
  Neurocognitive                                                                                                                                                                                                                             
  Reaction time              *M*     98.60                                                                96.43                                                                86.68                                                         
  SD                         20.23                                                                12.86                                                                29.62                                                                 
  *d*                                0.13                                                                 0.43                                                                 0.47                                                          
  Complex attention          *M*     94.25                                                                87.00                                                                73.24                                                         
  SD                         19.76                                                                18.95                                                                21.81                                                                 
  *d*                                0.37                                                                 0.67                                                                 1.01^[a](#table-fn2-1179069519833966){ref-type="table-fn"}^   
  Cognitive flexibility      *M*     102.55                                                               100.64                                                               80.72                                                         
  SD                         17.45                                                                13.89                                                                22.55                                                                 
  *d*                                0.12                                                                 1.06[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           1.08^[a](#table-fn2-1179069519833966){ref-type="table-fn"}^   
  Processing speed           *M*     104.35                                                               102.07                                                               92.04                                                         
  SD                         23.07                                                                12.53                                                                15.95                                                                 
  *d*                                0.12                                                                 0.67                                                                 0.62                                                          
  Executive functioning      *M*     105.55                                                               103.00                                                               83.92                                                         
  SD                         14.22                                                                12.23                                                                21.18                                                                 
  *d*                                0.19                                                                 1.10[\*](#table-fn3-1179069519833966){ref-type="table-fn"}           1.20^[a](#table-fn2-1179069519833966){ref-type="table-fn"}^   
  Verbal memory              *M*     95.55                                                                100.29                                                               87.04                                                         
  SD                         22.96                                                                19.86                                                                22.78                                                                 
  *d*                                0.22                                                                 0.62                                                                 0.37                                                          

Abbreviations: *d*, Cohen *d* effect size; *M*, mean; mTBI, mild traumatic brain injury; PTS, posttraumatic stress symptoms; SD, standard deviation.

*P* \< .05 pairwise comparisons (Bonferroni corrected) of control vs mTBI + PTS group.

*P* \< .05 pairwise comparisons (Bonferroni corrected).

The results of the MANOVA for neurocognitive scores, approached significance, F~(6,12)~ = 1.8, *P* = .055, $\eta_{p}^{2} = .17$ (Pillai Trace). Pairwise comparisons revealed the control group had significantly better scores than the mTBI + PTS group on CA, *P* = .004, CF, *P* = .001, and EF, *P* \< .001, but not on RT, PS, and VM, *P \> *.05. The mTBI + PTS group also had significantly lower scores in CF, *P* = .009, and EF, *P* = .005, compared with the PTS group. The findings suggest that both the PTS and mTBI + PTS groups have mild decrements in cognition compared with controls, but also the comorbid group has greater decrements than the PTS group ([Table 1](#table1-1179069519833966){ref-type="table"}).

Strength and variance of ROI connectivity {#section22-1179069519833966}
-----------------------------------------

The results of the MANOVAs for strength of connectivity (SFC; [Table 2](#table2-1179069519833966){ref-type="table"}) and variability of connectivity (vDFC; [Table 3](#table3-1179069519833966){ref-type="table"}) revealed significant differences across the 3 groups. Both PTS and mTBI + PTS groups were markedly different compared with controls ([Tables 2](#table2-1179069519833966){ref-type="table"} and [3](#table3-1179069519833966){ref-type="table"}).

###### 

MANOVAs (control vs PTS vs mTBI + PTS): static functional connectivity.

![](10.1177_1179069519833966-table2)

  Connection                                           F
  ---------------------------------------------------- -------
  L. precuneus ↔ R. precuneus                          12.85
  L. precuneus ↔ L. middle frontal gyrus               15.57
  L. middle temporal gyrus ↔ R. medial frontal gyrus   12.19
  L. precuneus ↔ L. middle temporal gyrus              13.02
  R. middle cingulate ↔ L. middle frontal gyrus        13.95
  L. middle cingulate ↔ L. middle frontal gyrus        12.37
  R. middle frontal gyrus ↔ L. middle frontal gyrus    12.72

Abbreviations: MANOVAs, multivariate analyses of variance; mTBI, mild traumatic brain injury; PTS, posttraumatic stress symptoms.

###### 

MANOVAs (control vs PTS vs mTBI + PTS): variance of dynamic functional connectivity.

![](10.1177_1179069519833966-table3)

  Connection                                          F
  --------------------------------------------------- -------
  L. dorsomedial PFC ↔ L. anterior cingulate          15.95
  L. middle frontal gyrus ↔ R. precuneus              14.38
  L. middle temporal pole ↔ R. middle cingulate       13.27
  L. dorsomedial PFC ↔ R. medial orbitofrontal        11.72
  R. precuneus ↔ L. dorsomedial PFC                   11.55
  L. precuneus ↔ L. dorsomedial PFC                   11.53
  L. precuneus ↔ R. dorsomedial PFC                   10.96
  L. middle frontal gyrus ↔ R. ventrolateral PFC      10.93
  L. dorsomedial PFC ↔ L. dorsomedial PFC             10.84
  L. anterior cingulate ↔ R. angular gyrus            10.71
  R. medial orbitofrontal ↔ R. precuneus              10.66
  R. precuneus ↔ L. middle frontal gyrus              10.64
  L. ventromedial PFC ↔ L. ventrolateral PFC          9.84
  L. dorsomedial PFC ↔ R. ventrolateral PFC           9.81
  L. middle temporal pole ↔ L. anterior cingulate     9.61
  R. medial orbitofrontal ↔ R. cerebellum crus 1      9.59
  R. rectus gyrus ↔ L. anterior cingulate             9.28
  L. dorsomedial PFC ↔ R. cerebellum crus 1           9.20
  L. middle frontal gyrus ↔ R. middle frontal gyrus   8.96
  L. middle frontal gyrus ↔ R. middle cingulate       8.94
  R. middle frontal gyrus ↔ L. ventrolateral PFC      8.85
  R. dorsomedial PFC ↔ R. ventrolateral PFC           8.67
  L. middle occipital ↔ R. middle frontal gyrus       8.47
  R. dorsomedial PFC ↔ R. ventrolateral PFC           8.46
  L. dorsomedial PFC ↔ L. dorsomedial PFC             8.40
  L. dorsomedial PFC ↔ L. dorsomedial PFC             8.39
  R. medial orbitofrontal ↔ L. ventrolateral PFC      8.30
  L. middle frontal gyrus ↔ L. dorsomedial PFC        8.22
  R. precuneus ↔ R. cerebellum crus 1                 8.00
  R. precuneus ↔ L. dorsomedial PFC                   7.99
  R. rectus gyrus ↔ R. precuneus                      7.98
  L. precuneus ↔ L. anterior cingulate                7.93
  L. precuneus ↔ L. dorsomedial PFC                   7.90
  R. angular gyrus ↔ L. dorsomedial PFC               7.84
  R. angular gyrus ↔ R. dorsomedial PFC               7.77
  L. middle frontal gyrus ↔ L. dorsomedial PFC        7.67
  L. dorsomedial PFC ↔ L. ventrolateral PFC           7.62
  R. dorsomedial PFC ↔ L. medial orbitofrontal        7.41
  R. precuneus ↔ R. dorsomedial PFC                   7.31
  L. anterior cingulate ↔ R. ventrolateral PFC        7.14

Abbreviations: MANOVAs, multivariate analyses of variance; mTBI, mild traumatic brain injury; PFC, prefrontal cortex; PTS, posttraumatic stress symptoms.

As observed in [Table 4](#table4-1179069519833966){ref-type="table"}, there was reduced connectivity strength between ROIs (SFC) in the PTS group ([Figure 2A](#fig2-1179069519833966){ref-type="fig"}), which were specific to regions that included the *prefrontal ↔ posterior cingulate, cingulate ↔ temporal*, and contralateral *temporal ↔ temporal* regions. In contrast, the mTBI + PTS group showed significantly reduced connectivity strength between only the right dorsomedial prefrontal cortex (dmPFC) and left medial temporal lobe (MTL; [Figure 2B](#fig2-1179069519833966){ref-type="fig"}). Compared with the mTBI + PTS group, the PTS group showed a greater number of connectivity abnormalities in SFC (3/1 = 67%). Contrary to our hypothesis that the comorbid group would have reduced strength in a greater number of connections, there were no significant differences between PTS and mTBI + PTS groups in SFC, implying that the strength of connectivity is compromised in both of these disorders and somewhat different among themselves.

###### 

Static functional connectivity (SFC) findings.

![](10.1177_1179069519833966-table4)

  Group contrast                    Connectivity between ROIs                                                                                                             
  --------------------------------- --------------------------- -------------------------- ----- ----- ----- ----- -------------------------- ----- ----- ----- --------- --------
  *Control* *\>* *PTS*                                                                                                                                                    
                                    15                          L. posterior cingulate     −11   −56   16    25    L. dorsolateral PFC        −35   20    51    5.077     15.568
                                    17                          R. middle cingulate        8     −48   31    45    L. middle temporal gyrus   −68   −41   −5    4.914     13.948
                                    41                          R. middle temporal gyrus   65    −12   −19   45    L. middle temporal gyrus   −68   −41   −5    5.014     12.721
  *PTS* *\>* *Control*                                          ---                                                ---                                          ---       
  *Control* *\>* *mTBI* *+* *PTS*                                                                                                                                         
                                    6                           L. middle temporal gyrus   −46   −61   21    35    R. orbitomedial PFC        8     42    −5    3.907     12.192
  *mTBI* *+* *PTS* *\>* *Control*   ---                                                                      ---                                          ---             
  *PTS* *\>mTBI* *+* *PTS*                                      ---                                                ---                                          ---       
  *mTBI* *+* *PTS* *\>* *PTS*                                   **---**                                            **---**                                      **---**   

Abbreviations: mTBI, mild traumatic brain injury; PFC, prefrontal cortex; PTS, posttraumatic stress symptoms; ROIs: regions of interest.

Variability of connectivity (vDFC) showed more differences across the groups ([Table 5](#table5-1179069519833966){ref-type="table"}). Both the PTS and mTBI + PTS groups showed reduced variability of *temporal ↔ cingulate* and *prefrontal ↔ cingulate* connectivities compared with controls ([Figure 3A](#fig3-1179069519833966){ref-type="fig"} and [B](#fig3-1179069519833966){ref-type="fig"}). However, only the PTS group showed increased vDFC, which primarily occurred between *prefrontal ↔ parietal* and *prefrontal ↔ temporal* regions ([Figure 3D](#fig3-1179069519833966){ref-type="fig"}).

###### 

Variance of dynamic functional connectivity (vDFC) findings.

![](10.1177_1179069519833966-table5)

  Group contrast                    Connectivity between ROIs                                                                                                            
  --------------------------------- --------------------------- ---------------------------- ----- ----- ----- ---- -------------------------- ----- ----- ----- ------- --------
  *Control* *\>* *PTS*                                                                                                                                                   
                                    10                          L. middle temporal gyrus     −68   −23   −16   17   R. middle cingulate        8     −48   31    4.256   8.940
                                    16                          L. posterior cingulate       −3    −49   13    29   L. dorsolateral PFC        −20   45    39    4.462   11.533
                                    8                           L. superior temporal gyrus   −44   12    −34   38   L. anterior cingulate      −3    42    16    4.143   9.611
                                    5                           L. ventromedial PFC          −18   63    −9    57   L. ventrolateral PFC       −46   31    −13   4.046   9.836
  *PTS* *\>* *Control*                                                                                                                                                   
                                    2                           R. orbitomedial PFC          6     67    −4    18   R. precuneus               15    −63   26    4.601   10.656
                                    18                          R. precuneus                 15    −63   26    37   L. dorsomedial PFC         −2    38    36    4.231   11.552
                                    18                          R. precuneus                 15    −63   26    40   L. dorsomedial PFC         −8    48    23    4.257   7.987
                                    23                          L. dorsomedial PFC           −10   39    52    58   R. ventrolateral PFC       49    35    −12   3.935   9.806
                                    42                          L. middle temporal gyrus     −56   −13   −10   58   R. ventrolateral PFC       49    35    −12   4.310   10.926
  *Control* *\>* *mTBI* *+* *PTS*                                                                                                                                        
                                    8                           L. superior temporal gyrus   −44   12    −34   17   R. middle cingulate        8     −48   31    4.888   13.266
                                    23                          L. dorsomedial PFC           −10   39    52    32   L. anterior cingulate      −7    51    −1    5.645   15.953
  *mTBI* *+* *PTS* *\>* *Control*                                                                                                                                        
                                                                ---                                                                                              ---     
  *PTS* *\>* *mTBI* *+* *PTS*                                   *x*                          *y*   *z*              *x*                        *y*   *z*                 
                                    10                          L. middle temporal gyrus     −68   −23   −16   14   R. precuneus               6     −59   35    5.085   14.383
                                    2                           R. orbitomedial PFC          6     67    −4    18   R. occipital/precuneus     15    −63   26    3.848   10.656
                                    3                           R. ventromedial PFC          8     48    −15   18   R. occipital/precuneus     15    −63   26    3.977   7.980
                                    2                           R. orbitomedial PFC          6     67    −4    19   L. middle cingulate        −2    −37   44    3.842   6.299
                                    4                           L. precuneus                 −13   −40   1     26   R. dorsolateral PFC        22    39    39    3.722   10.956
                                    23                          L. dorsomedial PFC           −10   39    52    32   L. anterior cingulate      −7    51    −1    4.528   15.953
                                    23                          L. dorsomedial PFC           −10   39    52    35   R. orbitomedial PFC        8     42    −5    4.163   11.720
                                    18                          R. occipital/precuneus       15    −63   26    37   L. dorsomedial PFC         −2    38    36    3.751   11.552
                                    23                          L. dorsomedial PFC           −10   39    52    37   L. dorsomedial PFC         −2    38    36    3.716   8.390
                                    25                          L. dorsolateral PFC          −35   20    51    39   L. frontopolar             −20   64    19    3.938   8.222
                                    25                          L. dorsolateral PFC          −35   20    51    41   R. middle temporal gyrus   65    −12   −19   3.747   8.963
                                    42                          L. middle temporal gyrus     −56   −13   −10   48   R. middle temporal gyrus   52    −2    −16   3.709   6.014
                                    18                          R. occipital/precuneus       15    −63   26    52   R. cerebellum              28    −77   −32   4.113   7.995
                                    24                          L. dorsolateral PFC          −16   29    53    57   L. ventrolateral PFC       −46   31    −13   4.124   6.094
                                    25                          L. dorsolateral PFC          −35   20    51    57   L. ventrolateral PFC       −46   31    −13   4.059   6.729
                                    35                          R. orbitomedial PFC          8     42    −5    57   L. ventrolateral PFC       −46   31    −13   4.510   8.304
                                    23                          L. dorsomedial PFC           −10   39    52    58   R. ventrolateral PFC       49    35    −12   4.012   9.806
                                    30                          R. dorsomedial PFC           6     54    16    58   R. ventrolateral PFC       49    35    −12   3.639   8.671
  *mTBI* *+* *PTS* *\>* *PTS*                                                                                                                                            
                                    6                           L. middle temporal gyrus     −46   −61   21    28   L. dorsolateral PFC        −10   55    39    3.913   7.667
                                    9                           R. middle temporal pole      46    16    −30   28   L. dorsolateral PFC        −10   55    39    3.596   6.028
                                    14                          R. precuneus                 6     −59   35    42   L. middle temporal gyrus   −56   −13   −10   4.129   10.637

Abbreviations: mTBI, mild traumatic brain injury; PFC, prefrontal cortex; PTS, posttraumatic stress symptoms; ROIs: regions of interest.

As hypothesized, when comparing the mTBI + PTS group to the PTS group, the mTBI + PTS group showed a higher number of *prefrontal ↔ parietal* and *prefrontal ↔ prefrontal* connectivities ([Figure 3C](#fig3-1179069519833966){ref-type="fig"}) with reduced variability (18/3 = 83%). In contrast, the PTS group had reduced variability in just 3 connectivities constituting *prefrontal ↔ temporal* and *parietal ↔ temporal* regions compared with the mTBI + PTS group in vDFC (9/2 = 78%; [Figure 3E](#fig3-1179069519833966){ref-type="fig"}).

Overall, the findings reveal a pattern that suggests reduced strength and variance of connectivities that included prefrontal, temporal, and cingulate regions in the mTBI + PTS group, which suggests compromised neural efficiency.^[@bibr11-1179069519833966],[@bibr21-1179069519833966]^ This might contribute to the severity of the clinical symptoms and cognitive decrements observed in this comorbid group.

These findings suggest compromised DMN connectivity in PTS and mTBI + PTS, with increased variability of connectivity in one part of the DMN and reduced variability in another. While there were no significant differences in connectivity strength between the mTBI + PTS and PTS groups, variability of connectivity was able to distinguish them, which is an interesting and important finding because most studies ignore variability of connectivity.

Connectivity predictors of clinical symptoms and neurocognitive function {#section23-1179069519833966}
------------------------------------------------------------------------

In accord with our predictions that deficits in central EF and greater psychological health symptoms are also likely to be associated with dysregulated neurocircuitry, the results of the PLS regression analyses showed that the 47 connectivities, which significantly varied across the 3 groups, were significantly associated with both scores of clinical symptom severity (*R* = 0.51, *R*^2^ = 0.26, *P* = 3.9 × 10^−9^) and neurocognitive functioning (*R* = 0.51, *R*^2^ = 0.26, *P* = 2.4 × 10^−9^), explaining 26% variance in each of them. These findings suggest that a large percentage of the variance in both clinical symptoms and neurocognitive function can be attributed to compromised efficiency of the neural network underpinning the DMN in soldiers who experienced psychological and neurologic trauma.

More specifically, greater SFC and vDFC connectivity of the left *dlPFC ↔ precuneus* was associated with higher neurocognitive scores and lower clinical symptom scores. In other words, weaker and less variable connections between these ROIs were linked with poorer overall neuropsychological outcomes. Connectivity between these ROIs has been implicated in self-referential processing. In addition, the fact that both regions are from the left hemisphere is interesting given that the left hemisphere predominantly processes negative emotions compared with the right.

Discussion {#section24-1179069519833966}
==========

This study revealed significant group differences between active-duty Army soldiers with PTS and mTBI with comorbid PTS compared with matched controls on a number of different symptom, neurocognitive, and neuroimaging measures. Overall, lower performance on neurocognitive tests and clinical symptoms were on the order of severity from mTBI + PTS \> PTS \> Controls. There were differences between the PTS and mTBI + PTS groups in terms of reduced connectivity strength compared with controls. While the PTS group showed reduced strength in *frontal-cingulate-temporal* connectivities, the mTBI + PTS had reduced strength in only one connection (omPFC *↔* middle temporal gyrus \[MTG\]) constituting part of the *frontal-temporal* network. Both groups showed decreased variability of *frontal-cingulate-temporal* regions of the attention network. Interestingly, the PTS group, which was less severe than the comorbid group in terms of clinical symptoms, showed a greater number of abnormal connectivities compared with the mTBI + PTS group (9/2 = 78%). Another key finding not observed in the more severe mTBI + PTS group was the PTS group's increased variability of the *frontal-parietal* attention network, which has been implicated in achieving and maintaining an alert state. Although the bulk of the abnormal connectivities accounted for a significant percentage of the variance in clinical and neurocognitive measures for the groups when combined, both strength (SFC) and variability (vDFC) of connectivity of the left dlPFC *↔* precuneus were associated with higher neurocognitive scores and lower clinical symptoms scores.

The dlPFC has been implicated in a number of neuropsychological processes such as regulating attention and executive functions such as planning of future actions, taking initiative, and working memory and attention.^[@bibr42-1179069519833966],[@bibr43-1179069519833966]^ Connections between the left dlPFC and precuneus have been implicated in cognitive processes such as attentional shifting during mental sets or rules.^[@bibr44-1179069519833966]^ Cognitive impairments are commonly associated with PTSD,^[@bibr4-1179069519833966]^ including compromised performance on emotion-based tasks.^[@bibr3-1179069519833966],[@bibr7-1179069519833966]^ Evidence suggests that cognitive impairments in PTSD may be due to accentuated affective processes and attenuated dlPFC-related processes and compromised regulatory network.^[@bibr7-1179069519833966],[@bibr45-1179069519833966]^ Although our PTS group did not have significantly lower neurocognitive scores than the control group, the mTBI + PTS group showed significant decrements in CA, CF, and EF. Our findings that the PTS and mTBI + PTS groups had weaker and less stable connections may have contributed to these individuals having difficulty in regulating attention to intrinsic thoughts, feelings, sensations, and/or images while in a resting state. The dlPFC has been implicated in language processes.^[@bibr46-1179069519833966]^ Increased variability in connectivity between the dlPFC and cingulate cortex for both the PTS and mTBI + PTS groups compared with controls might suggest the propensity for perseverative self-talk.

The precuneus, the medial part of the superior parietal lobe appears to have a prominent role in the DMN.^[@bibr17-1179069519833966],[@bibr47-1179069519833966]^ The region has been implicated in mental imagery concerning the self^[@bibr48-1179069519833966]^ and episodic memory.^[@bibr49-1179069519833966]^ Furthermore, decreased connectivity of the precuneus has been observed in war veterans with PTSD.^[@bibr50-1179069519833966]^ Our findings suggest that abnormal connectivity between the precuneus and other regions (especially the dmPFC) might reflect disrupted functional connections within the neural network associated with forming mental representations.^[@bibr46-1179069519833966]^ Although hypothetical, this might be explained by the PTS group being more engaged in mental imagery compared with controls while in a resting state.

It is easy to assume that the total number of abnormal connectivities would be a direct proxy of clinical severity. However, this is not supported by our findings in that the mTBI + PTS was more severe than the PTS alone group as assessed via clinical symptoms and cognitive decrements, but had fewer abnormal connectivities overall when compared with controls. As such, it is likely that the combination of ROIs that constitute the disrupted connectivities has a greater impact on functioning than the mere number of disrupted connectivities.

Connectivity and neurobehavioral measures {#section25-1179069519833966}
-----------------------------------------

Only one connection, which included connectivity strength (SFC) and variability (vDFC) between the dlPFC and precuneus, exhibited significant associations with the different neurobehavioral measures. Interestingly, stronger and more variable connectivity was associated with higher neurocognitive scores and lower clinical symptom scores. As such, flexibility, or lack thereof, of this *frontal ↔ posterior* neurocircuitry seems to be implicated in both cognitive and affective processes that have a direct impact on behavior and symptoms. Greater strength and flexibility contribute to more efficiency in neurocognitive functioning, whereas weaker and reduced flexibility or rigidity results in compromised functioning.^[@bibr11-1179069519833966],[@bibr21-1179069519833966]^ These top-down processes are necessary for efficiency of regulatory processes (eg, emotional regulation), and therefore, when compromised may negatively impact one's ability to recover and/or cope with stressors (ie, intrinsic and extrinsic). In essence, the integrity of top-down functions implemented in regulation of emotion could contribute to the development and maintenance of trauma-related symptoms, whether this is of psychological or neurological etiology.

Limitations {#section26-1179069519833966}
-----------

There were a few limitations that should be highlighted. First, reproducibility of our findings is necessary to show reliability. Without reliability, it cannot be guaranteed that our sample of subjects is representative of the clinical population in the Army, other branches of the Armed Forces, or general population to include civilians. The lack of robust abnormal connectivities in the mTBI + PTS group may reflect a generalized dampening of the DMN, associated with either medication use or injury pathophysiology. Indeed, many of our subjects were using prescribed medications for treatment of their conditions. Future studies should attempt to recruit subjects who are not being treated with psychotropic medication, as well as explore the impact of specific medications on the DMN. Furthermore, we did not have a pure mTBI group (ie, absent of PTSD symptoms) or true PTSD group to assess whether the DMN findings were due to the combination of mTBI and PTS or mTBI alone. Prior studies have shown that PTSD is a partial mediator of mTBI symptomatology.^[@bibr51-1179069519833966]^ However, we did not run mediation analyses or control for PTSD symptoms as a covariate. Future studies should attempt to compare PTSD versus mTBI alone to better understand the impact of mTBI on DMN neurocircuitry. Finally, unbeknownst to us, there is evidence that hearing loss is associated with altered network connectivity.^[@bibr52-1179069519833966]^ Although military service members who were exposed to blast-related injuries are at risk for hearing loss,^[@bibr53-1179069519833966]^ we did not attain these data for this study. As such, it is important that future studies on mTBI in military populations acquire the necessary data to address this confound.

Conclusions {#section27-1179069519833966}
===========

Overall, we interpret the findings to suggest that PTS, with and without mTBI, is associated with less stable and disrupted neural signature during resting state. However, the number of disrupted connectivities does not appear to reflect clinical severity in that the PTS group, although having lower symptom scores, had a greater number of abnormal connectivities than the mTBI + PTS group. Furthermore, weaker and less variable connectivity of the dlPFC and precuneus was associated with worse neuropsychological outcomes. In other words, weaker and less variable connections between these ROIs were linked with poorer overall neuropsychological outcomes. Being that the dlPFC is associated with attention and executive functions and the precuneus with self-related mental representations during rest,^[@bibr52-1179069519833966]^ these regions potentially have a functional role in that underlies unprovoked generation of thoughts, feelings, sensations, and/or images in service members with PTS and mTBI + PTS. While there were no significant differences in DMN connectivity strength between the mTBI + PTS and PTS groups, variability of connectivity was able to distinguish them, which is an interesting and important finding because most studies ignore variability of connectivity.

Supplemental Material {#section28-1179069519833966}
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